BIOSYNEX |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.22 EUR | +0.48% |
|
-20.38% | -49.46% |
| Apr. 30 | Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 29 | Biosynex: agreement for ProciseDx in North America | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 48.27M | - | - | - | - | - | |
| 7.67B | ||||||
| 5.41B | ||||||
| 4.62B | - | - | ||||
| 4.57B | ||||||
| 3.22B | - |
- Stock Market
- Equities
- ALBIO Stock
- Charts Biosynex
- Sector Chart
